Clinicopathological characteristics and change pattern of prostate cancer: IUPU 15-year experience

来源 :第十三届亚洲泌尿外科学会年会(UAA2015)、第二十二届全国泌尿外科学术会议(CUA2015)、第十六届全军及武警泌尿 | 被引量 : 0次 | 上传用户:jdalian1417
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
To analyze the clinicopathological characteristics and change pattern of prostate cancer (PCa) in the Institute of Urology, Peking University (IUPU) during the last 15 years.We reviewed the data of patients with biopsy confirmed and surgery confirmed PCa in IUPU during the last 15 years, which were chronologically divided into 2 groups, 2001-2010 and 2011-2015, respectively.The clinicopathological data between groups were compared.We identified 2313 patients with biopsy confirmed PCa and 1030 patients with surgery confirmed PCa.For the patients with biopsy and surgery confirmed PCa, the mean age were 70.67 ± 0.18 and 65.78 ± 0.28,respectively.We found a significant difference in the Gleason score between the patients with biopsy and surgery confirmed PCa (7.75 ± 0.03 vs.7.32 ± 0.03, P<0.001).The median number of cores was 12 (range 3-19) with only 28.9% ≤ 11.For the biopsy patients, there were significant difference in both core number (P<0.001) and Gleason score (P<0.001) between the group 2001-2010 (n=1094, 11.23 ± 0.10, 7.89 ± 0.04) and 2011-2015 (n=1218,11.81 ± 0.09, 7.62 ± 0.03).For the patients with surgery confirmed PCa, there was no difference in Gleason score (P=0.085) or age (P=0.699) between the group 2001-2010 (n=412) and 2011-2015 (n=618).There was a trend of T3 increase that the percentage of T3 was 47.4% and 52.6% in group 2001-2010 and 2011-2015, respectively.However, the difference was not significant (P=0.110).
其他文献
目的:探讨3D打印辅助认知融合对提高前列腺穿刺阳性率的作用.方法:2014年8月至2014年11月,对16例经多参数MRI发现可疑前列腺癌病灶的患者进行前列腺3D建模、计算机模拟穿刺、3D打印及认知融合下靶向穿刺.所有患者穿刺前均通过3.0T多参数MRI检查并发现可疑灶,8例患者可疑灶位于外周带,其余8例患者可疑灶位于尖部、中央叶等非典型区域.将MRI的DICOM格式文件导入医学影像处理软件进行3
会议
回顾分析北京大学泌尿外科研究所近15年收治肾癌伴下腔静脉瘤栓患者资料,探讨围手术期治疗经验及手术策略.2000年1月至2015年6月,本中心共收治184例肾癌伴下腔静脉瘤栓患者.收集患者临床信息及围手术期资料并进行统计分析.184例患者中下腔静脉Ⅰ级(肝静脉水平以下)、Ⅱ级(肝静脉至膈水平)、Ⅲ级瘤栓(膈上)分别为103例、49例及32例.男性患者129人(70.1%),女性患者55人(29.9%
会议
Objective: Introducing experience of urinary diversion utilizing orthotopic detaenial sigmoid neobladder after radical cystectomy in 4 centers of China, from Feb, 2002 to May, 2014.And to evaluate sho
会议
The AdVance sling is being increasingly used for the management of mild-moderate post-prostatectomy incontinence (PPI).The objective of this study was to determine long-term durability of the AdVance
会议
Many studies have represented the association between end-stage renal disease (ESRD) and malignancy.The predominant malignancy tumor occurs in patients with ESRD in Asian countries is urotheliai carci
会议
Although tyrosine kinase inhibitors (TKIs) currently play central roles in the treatment of patients with metastatic renal cell carcinoma (mRCC), TKIs are frequently associated with adverse events (AE
会议
To evaluate oncologic outcomes of segmental ureterectomy (SU) compared with radical nephroureterectomy (RNU) for ureter urothelial carcinoma of stage Ta, TI and T2.To evaluate whether tumor position i
会议
The incidence of prostate cancer (PCa) is reported to be increasing in Japan.This has been attributed to a more westernized diet and to changes in lifestyle.However, these assumptions may involve vari
会议
In management of upper urinary tract (renal pelvis and ureter)the urothelial carcinoma (transitional cell carcinoma), the standard surgical procedure is conventional open nephroureterectomy (ONU) with
会议
Management of high-risk prostate cancer (PCa) is still controversial.Aim of this study was to report outcome of radical prostatectomy (RP) or high-dose-rate brachytherapy (HDR) for the patients with l
会议